Literature DB >> 17226917

A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.

Ferenc Nagy1, Tamas Molnar, Eva Makula, Ildiko Kiss, Peter Milassin, Eva Zollei, Laszlo Tiszlavicz, Janos Lonovics.   

Abstract

The early hypersensitivity reaction and late bone marrow depression are well-known side-effects of azathioprine, whereas interstitial pneumonia is a rare complication. A 40-year old male patient had been treated with azathioprine in consequence of extensive ulcerative colitis for 10 years. He then complained of 7 d of fever, cough and catarrhal signs, without symptoms of active colitis. Opportunistic infections were ruled out. The chest X-ray, CT and lung biopsy demonstrated the presence of interstitial inflammation. Azathioprine therapy was discontinued as a potential source of the pulmonary infiltrate. In response to steroid therapy, and intensive care, the pulmonary infiltrate gradually decreased within 4 wk. Three months later, his ulcerative colitis relapsed, and ileo-anal pouch surgery was performed. In cases of atypical pneumonia, without a proven infection, azathioprine-associated interstitial pneumonitis may be present, which heals after withdrawal of the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226917      PMCID: PMC4065966          DOI: 10.3748/wjg.v13.i2.316

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 2.  Review article: practical management of inflammatory bowel disease patients taking immunomodulators.

Authors:  C A Siegel; B E Sands
Journal:  Aliment Pharmacol Ther       Date:  2005-07-01       Impact factor: 8.171

Review 3.  Inflammatory bowel disease: current therapeutic options.

Authors:  Eugeni Domènech
Journal:  Digestion       Date:  2006-02-08       Impact factor: 3.216

4.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors:  A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal:  BMJ       Date:  1992-07-04

Review 5.  [Conservative therapy of inflammatory bowel diseases].

Authors:  Ferenc Nagy
Journal:  Orv Hetil       Date:  2002-12-15       Impact factor: 0.540

6.  Azathioprine-associated interstitial pneumonitis.

Authors:  C W Bedrossian; J Sussman; R H Conklin; B Kahan
Journal:  Am J Clin Pathol       Date:  1984-08       Impact factor: 2.493

Review 7.  Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.

Authors:  Marla C Dubinsky
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

8.  CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes.

Authors:  Imke Tiede; Gerhard Fritz; Susanne Strand; Daniela Poppe; Radovan Dvorsky; Dennis Strand; Hans Anton Lehr; Stefan Wirtz; Christoph Becker; Raja Atreya; Jonas Mudter; Kai Hildner; Brigitte Bartsch; Martin Holtmann; Richard Blumberg; Henning Walczak; Heiko Iven; Peter R Galle; Mohammad Reza Ahmadian; Markus F Neurath
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

  8 in total
  7 in total

1.  Organizing pneumonia: a rare pulmonary manifestation of well-controlled ulcerative colitis.

Authors:  Xiaoming Zhou; Yu Chen; Li Zhao
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  Acute respiratory distress syndrome associated with severe ulcerative colitis.

Authors:  Shiho Sagara; Yasuo Horie; Yumiko Anezaki; Hideaki Miyazawa; Masahiro Iizuka
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 3.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

4.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 5.  Use of thiopurines in inflammatory bowel disease: Safety issues.

Authors:  Anastasia Konidari; Wael El Matary
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

6.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

7.  Hypersensitivity pneumonitis associated with azathioprine therapy in a patient with granulomatosis with polyangiitis.

Authors:  In Hee Lee; Gun Woo Kang; Kyung Chan Kim
Journal:  Rheumatol Int       Date:  2016-05-07       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.